Ontology highlight
ABSTRACT: Background
Dual antiplatelet therapy with clopidogrel and aspirin is the primary treatment for patients who undergo percutaneous coronary intervention. However, the interindividual difference in clopidogrel response is remarkable, and high on-treatment platelet reactivity (HTPR) can increase the risk of thrombotic events after percutaneous coronary intervention.Objective
We studied novel accessible factors that possibly affect clopidogrel response in DNA methylation.Methods
Methylation 850K bead chips were used to detect DNA methylation levels. The platelet reactivity index (PRI) was determined in 330 subjects with acute coronary syndrome (ACS) after administration of clopidogrel 300 mg loading dose or at least 5 days of 75 mg daily maintenance dose.Results
SUBMITTER: Song PY
PROVIDER: S-EPMC10031538 | biostudies-literature | 2023 Feb
REPOSITORIES: biostudies-literature